Marico Innovation Foundation and Villgro, a social enterprise incubator, have invested an undisclosed amount in Bengaluru-based medical technology start-up Yostra.

Yostra Labs, which has developed two devices to diagnose and treat complications arising out of diabetes, will use the money to complete the clinical validation of the products, Beta test them and manufacture them.

According to Vinayak Nandalike, founder, Yostra, the company has developed a diagnostic device called Sparsh for diabetic peripheral neuropathy and a treatment device called Kadam for diabetic foot ulcers. Both are in the clinical validation phase, he told BusinessLine over telephone. While Sparsh has been given to the first set of doctors for validation, Kadam will shortly be given to St John’s Medical College Hospital for testing.

He said Yostra was looking at whether it could make the devices on its own or get them manufactured outside. The thinking was that it would get parts made outside and assemble the devices by itself. According to Nandalike, Yostra, founded in August 2014, has been bootstrapped till now. It had received a ₹47-lakh grant from the Centre. A mechanical engineer and an MBA, Nandalike worked in Robert Bosch for eight years and with consultancy firm Accenture for four years before starting Yostra with three others.

A press release issued by Villgro said a significant portion of the investment would go into building a team that could continue to build more innovative devices.